{{chembox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 444560893
| ImageFile=Motretinide.png
| IUPACName=N-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenamide
| OtherNames=
|Section1={{Chembox Identifiers
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = W786807KL1
| CASNo_Ref = {{cascite|correct|??}}
| CASNo=54757-59-4
| EINECS = 260-094-6
| PubChem = 6314185
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 4880635
| SMILES = CCNC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C(=C(C=C1C)OC)C)C
| InChI = 1/C23H31NO2/c1-8-24-23(25)14-17(3)11-9-10-16(2)12-13-21-18(4)15-22(26-7)20(6)19(21)5/h9-15H,8H2,1-7H3,(H,24,25)/b11-9+,13-12+,16-10+,17-14+
| InChIKey = IYIYMCASGKQOCZ-DJRRULDNBU
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C23H31NO2/c1-8-24-23(25)14-17(3)11-9-10-16(2)12-13-21-18(4)15-22(26-7)20(6)19(21)5/h9-15H,8H2,1-7H3,(H,24,25)/b11-9+,13-12+,16-10+,17-14+
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = IYIYMCASGKQOCZ-DJRRULDNSA-N
| RTECS = 
| MeSHName = 
| ChEBI = 
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG = D05082
  }}
|Section2={{Chembox Properties
| Formula=C<sub>23</sub>H<sub>31</sub>NO<sub>2</sub>
| MolarMass=353.49774
| Appearance=
| Density=
| MeltingPt=
| BoilingPt=
| Solubility=
  }}
|Section6={{Chembox Pharmacology
| ATCCode_prefix = D10
| ATCCode_suffix = AD05
}}
|Section7={{Chembox Hazards
| MainHazards=
| FlashPt=
| AutoignitionPt =
  }}
}}
'''Motretinide''' is an anti-[[Acne vulgaris|acne]] [[Drug|preparation]] and aromatic analog of retinoic acid.<ref>{{Cite journal 
| last1 = Zouboulis | first1 = C. C. 
| title = Retinoids--which dermatological indications will benefit in the near future? 
| journal = Skin pharmacology and applied skin physiology 
| volume = 14 
| issue = 5 
| pages = 303â€“315 
| year = 2001 
| pmid = 11586072
}}</ref> 

==References==
{{reflist}}

{{Acne agents}}

[[Category:Anti-acne preparations]]

{{dermatologic-drug-stub}}